30 Jun, 2019 Exponential: Martin Tolar alzheon2019-09-23T12:10:46-04:00June 30th, 2019|Tags: Newstalk 1010| Read More
17 Jul, 2017 Alzheon updates on precision medicine approach to treating AD alzheon2019-09-23T12:10:48-04:00July 17th, 2017|Tags: thepharmaletter| Read More
23 Jun, 2017 Alzheon says data backs potential of Alzheimer’s candidate alzheon2019-09-23T12:10:49-04:00June 23rd, 2017|Tags: PMLiVE| Read More
2 Jun, 2017 Insights from discovery through clinical efficacy to support a new class of therapeutics in Alzheimer’s disease alzheon2019-09-23T12:10:49-04:00June 2nd, 2017|Tags: Drug Target Review| Read More
25 Oct, 2016 ‘Gene-dose’ effect for Alzheon’s ALZ-801, a drug targeting Alzheimer’s disease alzheon2019-09-23T12:10:52-04:00October 25th, 2016|Tags: thepharmaletter| Read More
7 Oct, 2016 A Little-Known Drug Company Could Have The Answer For Some Alzheimer’s Patients alzheon2019-09-23T12:10:52-04:00October 7th, 2016|Tags: Forbes.com| Read More
25 Jul, 2016 Alzheimer’s biotech Alzheon to move once-failed drug into new PhIII alzheon2024-07-10T14:05:18-04:00July 25th, 2016|Tags: fiercebiotech.com| Read More
26 Jan, 2016 Alzheon Highlighted as One of the “Top 20 Life Science Startups to Watch in the U.S.” alzheon2019-09-23T12:10:53-04:00January 26th, 2016|Tags: BioSpace.com| Read More